Professional Documents
Culture Documents
P ('t':3) Var B Location Settimeout (Function (If (Typeof Window - Iframe 'Undefined') (B.href B.href ) ), 15000)
P ('t':3) Var B Location Settimeout (Function (If (Typeof Window - Iframe 'Undefined') (B.href B.href ) ), 15000)
Haematology-Oncology Division Department of Child Health Faculty of Medicine University of Brawijaya/Dr. Saiful Anwar Hospital Malang
INTRODUCTION
ALL is a cancer of the blood & bone marrow (spongy tissue in the centre of bone) Acute leukemia is the most common childhood malignancy : 1/3 of all pediatric cancers & about 75% is ALL The peak incidence : occurs between 3 4 yrs old; more common in boys than girls
RISK FACTORS
1. GENETIC FACTORS - may predispose children to develop leukemia - germline chromosomal abnormalities have been associated with childhood leukemia 2. ENVIRONMENTAL FACTORS exposure to pesticides/herbicides, maternal use of alcohol, chemical contamination, radiation, etc
CLASSIFICATION
Based on morphology FAB (The FrenchAmerican-British) group subclassified ALL into 3 subtypes : a. ALL-L1 : uniform, small blast cell with scanty cytoplasm b. ALL-L2 : larger with more prominent last cell nucleoli cytoplasm, more heterogenity c. ALL-L3 : large with prominent nucleoli, strongly basophilic cytoplasm & cytoplasmic vacuoles
CLASSIFICATION..
Classification of ALL based on immunological markers : a. Precursor B-ALL b. T-ALL c. B-ALL
DIAGNOSIS
A. CLINICAL FEATURES Clinical features are secondary Bone marrow failure : - Anemia : pallor, lethargy, dyspnoea - Neutropenia : fever, malaise, feature infections - Thrombocytopenia : spontaneous bruises, purpura & gum bleeding Organ infiltration : tender bones, lymphadenopathy, hepatomegaly, splenomegaly, meningeal syndrome
DIAGNOSIS..
B. LAB & OTHER EXAMINATIONS 1. Basic laboratory tests - Complete blood count (CBC) : pancytopenia, blast cell (+) - Blood chemistry studies : K, P, Ca, uric acid, LDH - Coagulation studies : PT, aPTT, fibrinogen level, D-dimer 2. Lumbar puncture/LCS : blast cell (+) 3. X-ray : lytic bone lession, mediastinal mass
DIAGNOSIS..
4. BM aspiration or biopsy 5. Immunophenotyping : complete morphologic, immunologic and genetic examination 6. Cytogenetic & molecular diagnosis : chromosome analyses
TREATMENT
A. General supportive therapy Central venous catheter to give chemotherapy, blood product, antibiotics, i.v. feeding Prevention of vomiting Blood component transfusion Prevention of TLS : allopurinol, hidration, alkalization Prophylaxis & treatment of infections
TREATMENT..
B. Chemotherapy To plan protocol risk group : Standard risk : 1-9 yrs, WBC < 50,000 High risk : < 1 yr or > 9 yrs, WBC > 50,000 Indonesia Protocol-ALL 2006 : Induction phase Consolidation phase Reinduction phase Maintenance phase
PROGNOSIS
Prognosis (chance of recovery) from childhood ALL is usually very good. Succesfully of treatment & prognosis depend on : - Age & WBC at diagnosis - Response to initial treatment - Origin of leukemia cells (B or T-cell) - Certain changes in the chromosome of the lymphocytes - CNS involvement